SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+16.46%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$484M
AUM Growth
+$484M
(+3.3%)
Cap. Flow
-$60.5M
Cap. Flow
% of AUM
-12.49%
Top 10 Holdings %
Top 10 Hldgs %
55.19%
Holding
34
New
3
Increased
8
Reduced
21
Closed
2
Top Buys
| 1 |
Medtronic
MDT
|
$24.5M |
| 2 |
Gilead Sciences
GILD
|
$18M |
| 3 |
CERN
Cerner Corp
CERN
|
$5.85M |
| 4 |
HCA Healthcare
HCA
|
$3.42M |
| 5 |
Merck
MRK
|
$2.23M |
Top Sells
| 1 |
Incyte
INCY
|
$18.4M |
| 2 |
United Therapeutics
UTHR
|
$15.4M |
| 3 |
Johnson & Johnson
JNJ
|
$12.3M |
| 4 |
Abbott
ABT
|
$9.91M |
| 5 |
Boston Scientific
BSX
|
$9.11M |
Sector Composition
| 1 | Healthcare | 98.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$96B
| $37.9M | 7.82% | 644,533 -32,900 | -5% | -$1.93M |
|
|
2
Gilead Sciences
GILD
$140B
| $33.4M | 6.89% | 433,784 +234,365 | +118% | +$18M |
|
|
3
Merck
MRK
$210B
| $31.1M | 6.41% | 401,595 +28,900 | +8% | +$2.23M |
|
|
4
Incyte
INCY
$16.5B
| $28.7M | 5.92% | 275,987 -176,596 | -39% | -$18.4M |
|
5
Revvity
RVTY
$10.5B
| $25.3M | 5.22% | 257,722 -20,800 | -7% | -$2.04M |
|
|
6
Boston Scientific
BSX
$156B
| $25M | 5.16% | 711,482 -259,500 | -27% | -$9.11M |
|
|
7
Medtronic
MDT
$119B
| $24.5M | 5.05% | +266,800 | New | +$24.5M |
|
|
8
Abbott
ABT
$231B
| $23.9M | 4.94% | 261,939 -108,395 | -29% | -$9.91M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $19.4M | 4% | 172,780 +4,277 | +3% | +$480K |
|
10
Agilent Technologies
A
$35.7B
| $18.3M | 3.77% | 206,616 -50,100 | -20% | -$4.43M |
|
11
Elevance Health
ELV
$71.8B
| $18.1M | 3.75% | 69,002 -20,600 | -23% | -$5.42M |
|
|
NUVA
12
DELISTED
NuVasive, Inc.
NUVA
| $17.3M | 3.58% | 311,628 -3,200 | -1% | -$178K |
|
13
Biogen
BIIB
$19.4B
| $17.2M | 3.55% | 64,220 -10,900 | -15% | -$2.92M |
|
14
Perrigo
PRGO
$3.27B
| $16.1M | 3.32% | 290,593 -65,647 | -18% | -$3.63M |
|
15
Humana
HUM
$36.5B
| $14.1M | 2.92% | 36,457 -8,200 | -18% | -$3.18M |
|
16
Bruker
BRKR
$5.16B
| $13.7M | 2.83% | 337,346 +10,500 | +3% | +$427K |
|
17
BioMarin Pharmaceuticals
BMRN
$11.2B
| $13.4M | 2.76% | 108,482 -31,100 | -22% | -$3.84M |
|
18
Cardinal Health
CAH
$35.5B
| $12.3M | 2.53% | 234,792 +26,600 | +13% | +$1.39M |
|
19
Bio-Rad Laboratories Class A
BIO
$8.06B
| $11.9M | 2.45% | 26,270 -6,200 | -19% | -$2.8M |
|
20
Ionis Pharmaceuticals
IONS
$6.79B
| $11.2M | 2.31% | 189,981 -85,500 | -31% | -$5.04M |
|
|
PDCO
21
DELISTED
Patterson Companies, Inc.
PDCO
| $10.3M | 2.12% | 466,487 -63,730 | -12% | -$1.4M |
|
22
CVS Health
CVS
$92.8B
| $9.32M | 1.92% | 143,416 +22,556 | +19% | +$1.47M |
|
23
Ultragenyx Pharmaceutical
RARE
$2.89B
| $8.51M | 1.76% | 108,734 -36,338 | -25% | -$2.84M |
|
24
Quest Diagnostics
DGX
$20.3B
| $6.26M | 1.29% | 54,906 -58,136 | -51% | -$6.63M |
|
25
Alnylam Pharmaceuticals
ALNY
$58.5B
| $6.17M | 1.27% | 41,684 -12,700 | -23% | -$1.88M |
|